A new therapeutic approach to treat diabetic retinopathy.

Research unit

INNOSUISSE

Project number

101.499 IP-LS

Project title

A new therapeutic approach to treat diabetic retinopathy. (Innolink: 101.499 IP-LS)

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Pharmaceuticals
Abstract (English)	Diabetic retinopathy is the most common diabetes-specific complication that can lead to blindness due to microvascular damage and breakdown of the blood-retinal barrier. Based on our unique mode of action drug that increases cGMP levels, we aim to restore healthy ocular microcirculation.